IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 29 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  Search
 
  Next article
  Previous article 
  Table of Contents
  
Resource Links
   Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
   Article in PDF (166 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)

 
In This Article
   References

 Article Access Statistics
    Viewed1972    
    Printed77    
    Emailed1    
    PDF Downloaded107    
    Comments [Add]    

Recommend this journal

 


 
LETTER TO THE EDITOR
Year : 2010  |  Volume : 42  |  Issue : 4  |  Page : 254
 

The need for introducing medication vials tailored for pediatric use. Where do we stand?


Department of Pediatrics, Sri Lakshmi Narayana Institute of Medical Sciences, Pondicherry, India

Date of Web Publication13-Aug-2010

Correspondence Address:
T Arun Babu
Department of Pediatrics, Sri Lakshmi Narayana Institute of Medical Sciences, Pondicherry
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0253-7613.68441

Rights and Permissions



How to cite this article:
Babu T A, Venkatesh C. The need for introducing medication vials tailored for pediatric use. Where do we stand?. Indian J Pharmacol 2010;42:254

How to cite this URL:
Babu T A, Venkatesh C. The need for introducing medication vials tailored for pediatric use. Where do we stand?. Indian J Pharmacol [serial online] 2010 [cited 2021 Sep 24];42:254. Available from: https://www.ijp-online.com/text.asp?2010/42/4/254/68441


Sir,

Intravenous drug therapy is the corner stone of patient management in today's hospital practice and the discipline of pediatrics is no exception. The drug dosage in pediatrics is usually calculated according to the body weight or surface area leading to less cumulative dose when compared to adults. Unfortunately there are no separate pediatric drug dose formulations for most of the commonly used drugs. [1] It is a common practice to use a fraction of the adult dose vials (which is often an approximate dosage) and to store the remaining drug for future use. This leads to either wastage of precious medicines or a tendency to use pre-diluted, stored and contaminated medicine which may result in adverse reactions, loss of potency and efficacy. This may also be an underlying cause for nosocomial sepsis. [2]

Intravenous drug dosage for pediatric use is often limited by the strength of the drugs available commercially, especially in developing countries. [3] Most drug companies are hesitant to manufacture pediatric drug dosage vials due to greater intricacy and cost involved in drug development, relatively small trading volume and the presence of numerous unapproved drug formulations in use. The absence of pediatric specific formulations leaves more than a third of the world's population at an increased risk for avoidable adverse events, inappropriate dosing, non-adherence, and lack of access to novel drugs. [4]

Since in developing countries like India where sepsis is the leading cause of mortality necessitating the use of antibiotics , it is high time the medical fraternity realizes this potential lacuna in treating pediatric patients. We feel that the pharmaceutical majors should realize the urgent need to introduce commonly used drugs, especially life-saving medicines in doses suitable for pediatric use so that the basic right of every child to receive safe medication is not jeopardized.

 
  References Top

1.Nahata MC. Lack of pediatric drug formulations. Pediatrics 1999;104:607-9.  Back to cited text no. 1  [PUBMED]  [FULLTEXT]  
2.Harbarth S, Sudre P, Dharan S, Cadenas M, Pittet D. Outbreak of Enterobacter cloacae related to understaffing, overcrowding, and poor hygiene practices. Infect Control Hosp Epidemiol 1999;20:598-603.   Back to cited text no. 2  [PUBMED]  [FULLTEXT]  
3.Knoppert DC. Pediatric formulations: International issues and potential solutions. Paediatr Drugs 2009;11:55-6.  Back to cited text no. 3  [PUBMED]    
4.Milne CP, Bruss JB. The economics of pediatric formulation development for off-patent drugs. Clin Ther 2008;30:2133-45.  Back to cited text no. 4  [PUBMED]  [FULLTEXT]  




 

Top
Print this article  Email this article

    

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow